# Case Study of Medium Term Winners (Move the needle)

1.TOC
{:toc}

## NUE

![image](https://user-images.githubusercontent.com/27897180/119377062-872afd80-bc71-11eb-9d24-edb59e09a17c.png)

## SIVB
![image](https://user-images.githubusercontent.com/27897180/119382608-1daded80-bc77-11eb-95af-2feadf44076c.png)

## MRNA (early 220)
![image](https://user-images.githubusercontent.com/27897180/119383679-7cc03200-bc78-11eb-934e-5c8ae55bb796.png)

## SHOP (2019)
![image](https://user-images.githubusercontent.com/27897180/119384777-0fad9c00-bc7a-11eb-8b46-2c73727f5fb7.png)

## CELH (2020)
![image](https://user-images.githubusercontent.com/27897180/119385659-4c2dc780-bc7b-11eb-93ea-658cc11d588d.png)

## OSTK (2020)
![image](https://user-images.githubusercontent.com/27897180/119418355-b14de100-bcac-11eb-88a7-bcada6510bf7.png)

## BIDU (2017)
No clear entry
![image](https://user-images.githubusercontent.com/27897180/119418927-fb839200-bcad-11eb-9cf4-2730e9775fda.png)

## ENPH (2019)
5x in less than a year
![image](https://user-images.githubusercontent.com/27897180/119431546-a2285c80-bcc7-11eb-97ee-e96435086ff6.png)

## GS (late 2020/early 2021)
![image](https://user-images.githubusercontent.com/27897180/119499902-0bd25600-bd1c-11eb-86f2-87ad4b86d858.png)


